We are live on ! Find out more
ORKA

Oruka Therapeutics
ORKA

11 hedge funds and large institutions have $804K invested in Oruka Therapeutics in 2014 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 2

21% less funds holding

Funds holding: 14 → 11 (-3)

30% less capital invested

Capital invested by funds: $1.15M → $804K (-$347K)

50% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 6

Holders
11
Holders Change
-3
Holders Change %
-21.43%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
3
Reduced
2
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
+$78.3K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$16.6K
3
Citadel Advisors
Citadel Advisors
Florida
+$15.1K
4
Citigroup
Citigroup
New York
+$1.51K

Top Sellers

Rank Fund Capital Flow
1
BCM
Bridgeway Capital Management
Texas
-$150K
2
SKK
Shepherd Kaplan Krochuk
Massachusetts
-$124K
3
HighTower Advisors
HighTower Advisors
Illinois
-$19K
4
Goldman Sachs
Goldman Sachs
New York
-$15K
5
Ameriprise
Ameriprise
Minnesota
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$401K +$16.6K +11 +4%
VKH
2
Virtu KCG Holdings
New York
$97K +$78.3K +52 +325%
SKK
3
Shepherd Kaplan Krochuk
Massachusetts
$87K -$124K -82 -58%
AFM
4
Anson Funds Management
Texas
$81K +$84.4K +56 New
California Public Employees Retirement System
5
California Public Employees Retirement System
California
$44K – – –
Citadel Advisors
6
Citadel Advisors
Florida
$31K +$15.1K +10 +91%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$24K – – –
UBS Group
8
UBS Group
Switzerland
$21K +$22.6K +15 New
Bank of America
9
Bank of America
North Carolina
$14K -$1.51K -1 -9%
BIM
10
BlackRock Investment Management
Delaware
$3K – – –
Citigroup
11
Citigroup
New York
$1K +$1.51K +1 New
BCM
12
Bridgeway Capital Management
Texas
– -$150K -79 Closed
HighTower Advisors
13
HighTower Advisors
Illinois
– -$19K -10 Closed
Goldman Sachs
14
Goldman Sachs
New York
– -$15K -8 Closed
Ameriprise
15
Ameriprise
Minnesota
– -$12K -7 Closed
HRIA
16
Haberer Registered Investment Advisor
Ohio
– -$6K -3 Closed
TRCT
17
Tower Research Capital (TRC)
New York
– -$2K -1 Closed

ORKA Hedge Fund Activity: Q4 2014 in Review

11 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Oruka Therapeutics (ORKA) for Q4 2014, worth a combined $804K — down 30% from $1.15M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ORKA and 3 opened new positions — a net loss of 3 holders — while 2 trimmed existing stakes and 3 added.

The largest buyer was Virtu KCG Holdings, adding an estimated $78.3K. The largest seller was Bridgeway Capital Management, exiting entirely with an estimated $150K sold.

  • 11 institutional investors held Oruka Therapeutics (ORKA) as of Q4 2014, down from 14 in Q3 2014.
  • Funds reported $804K of Oruka Therapeutics stock for Q4 2014, down 30% quarter-over-quarter.
  • 3 funds opened new Oruka Therapeutics positions in Q4 2014 and 6 closed out, a net change of -3 holders.
  • The largest Oruka Therapeutics buyer in Q4 2014 was Virtu KCG Holdings, an estimated $78.3K added.
  • The largest Oruka Therapeutics seller in Q4 2014 was Bridgeway Capital Management, an estimated $150K sold.

Based on aggregated 13F filings for Q4 2014.